Taylor, R. S. et al. (2019) The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: a decision model-based analysis. European Journal of Preventive Cardiology, 26(12), pp. 1252-1261. (doi: 10.1177/2047487319833507) (PMID:30884975) (PMCID:PMC6628466)
|
Text
190684.pdf - Published Version Available under License Creative Commons Attribution Non-commercial. 231kB |
Abstract
Background: The REACH-HF (Rehabilitation EnAblement in CHronic Heart Failure) trial found that the REACH-HF home-based cardiac rehabilitation intervention resulted in a clinically meaningful improvement in disease-specific health-related quality of life in patients with reduced ejection fraction heart failure (HFrEF). The aims of this study were to assess the long-term cost-effectiveness of the addition of REACH-HF intervention or home-based cardiac rehabilitation to usual care compared with usual care alone in patients with HFrEF. Design and methods: A Markov model was developed using a patient lifetime horizon and integrating evidence from the REACH-HF trial, a systematic review/meta-analysis of randomised trials, estimates of mortality and hospital admission and UK costs at 2015/2016 prices. Taking a UK National Health and Personal Social Services perspective we report the incremental cost per quality-adjusted life-year (QALY) gained, assessing uncertainty using probabilistic and deterministic sensitivity analyses. Results: In base case analysis, the REACH-HF intervention was associated with per patient mean QALY gain of 0.23 and an increased mean cost of £400 compared with usual care, resulting in a cost per QALY gained of £1720. Probabilistic sensitivity analysis indicated a 78% probability that REACH-HF is cost effective versus usual care at a threshold of £20,000 per QALY gained. Results were similar for home-based cardiac rehabilitation versus usual care. Sensitivity analyses indicate the findings to be robust to changes in model assumptions and parameters. Conclusions: Our cost-utility analyses indicate that the addition of the REACH-HF intervention and home-based cardiac rehabilitation programmes are likely to be cost-effective treatment options versus usual care alone in patients with HFrEF.
Item Type: | Articles |
---|---|
Additional Information: | This work was supported by the United Kingdom’s National Institute for Health Research (NIHR) Programme Grants for Applied Research (grant number RP-PG-1210-12004). |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Taylor, Professor Rod |
Authors: | Taylor, R. S., Sadler, S., Dalal, H. M., Warren, F. C., Jolly, K., Davis, R. C., Doherty, P., Miles, J., Greaves, C., Wingham, J., Hillsdon, M., Abraham, C., Frost, J., Singh, S., Hayward, C., Eyre, V., Paul, K., Lang, C. C., and Smith, K. |
College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > MRC/CSO SPHSU |
Journal Name: | European Journal of Preventive Cardiology |
Publisher: | SAGE |
ISSN: | 2047-4873 |
ISSN (Online): | 2047-4881 |
Published Online: | 18 March 2019 |
Copyright Holders: | Copyright © 2019 The European Society of Cardiology |
First Published: | First published in European Journal of Preventive Cardiology 26(12):1252-1261 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record